Key result
Extensive catheter ablation fails to reduce atrial tachyarrhythmia recurrence vs limited ablation in pulmonary hypertension.
Why the study?
Does extensive catheter ablation reduce atrial tachyarrhythmia recurrence compared to limited ablation in patients with pulmonary hypertension?
RCT (n=74)
1:1
Yes
Does extensive catheter ablation reduce atrial tachyarrhythmia recurrence compared to limited ablation in patients with pulmonary hypertension?
Extensive catheter ablation does not significantly reduce long-term atrial tachyarrhythmia recurrence compared to limited ablation in patients with pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
Extended ablation was not associated with lower ATA recurrence; leaves open optimal strategy pending randomized trials in pulmonary hypertension.
Introduction The previously published randomized trial comparing an extensive (targeting both clinical arrhythmia and bi-atrial arrhythmogenic substrate) and a limited (clinical arrhythmia only) approach to catheter ablation in patients with pulmonary hypertension did not demonstrate a significant difference in atrial tachyarrhythmia (ATA) recurrence during the one-year follow-up. This study presents the long-term results of these patients. Methods Participants enrolled in the randomized trial (NCT04053361) were further followed and checked for ATA recurrence and all-cause mortality. Follow-up was primarily clinically driven, as the protocol for this secondary analysis was not fully prespecified Results A total of 74 patients [41 males, median age 71 years (IQR: 61; 75)] were randomized to the extended ( N = 36) and limited ( N = 38) ablation groups and followed for a median of 45 and 41 months, respectively. The ATAs recurred in 22 (61%) patients after extended vs. 19 (50%) patients after limited ablation [hazard ratio (HR) 1.22, 95% confidence interval (CI): 0.66–2.3]. There were 21 (58%) deaths in the extended ablation group, and 22 (58%) patients died during follow-up after the limited ablation (HR: 0.74, 95% CI: 0.39–1.4). No recurrence of typical atrial flutter was noted among the 23 patients treated by the ablation of the cavo-tricuspid isthmus. Conclusion Extensive catheter ablation in patients with pulmonary hypertension did not reduce ATA recurrence during the routine follow-up of more than 40 months. Cavo-tricuspid isthmus ablation appears effective in preventing recurrence of typical atrial flutter, even in this high-risk population. Given the exploratory nature of these analyses, further research is needed.
No takes yet. Share an insight, caveat, or question.
Dusík et al. (2026) conducted an RCT in Pulmonary hypertension and atrial tachyarrhythmia (n=74). Extended catheter ablation vs. Limited catheter ablation was evaluated on Documented atrial tachyarrhythmia recurrence lasting more than 30 s (HR 1.22, 95% CI 0.66-2.3). Extensive catheter ablation did not reduce atrial tachyarrhythmia recurrence compared to limited ablation in patients with pulmonary hypertension over a median follow-up of >40 months.
Synapse has enriched 10 related papers. Consider them for comparative context: